Nutrition and liver cirrhosis: a study of outcomes
Part of Hormones & metabolism clinical trials.
This study looks at how nutrition affects the health of people with liver cirrhosis (scarred liver) and aims to build a tool to predict their outcomes. If you have cirrhosis, joining may help researchers find better ways to support your health.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are diagnosed with liver cirrhosis (scarring of the liver) confirmed by ultrasound, CT, or MRI, and a FibroScan score over 17.5 kPa.
- Your estimated survival time is expected to be more than 3 months.
- You can make your own decisions and sign a consent form.
- You do not have primary liver cancer or a high AFP level (≥100 μg/L) for over 3 months.
- You have not had cancer (except basal cell skin cancer) in the last 5 years, and have no severe lung, heart, or other major diseases.
- You are not pregnant or breastfeeding, and have no recent serious mental health issues.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study is exploring a new way to predict how liver cirrhosis will progress. It may help doctors better understand and manage the condition.
This study looks at why some people with cirrhosis (liver scarring) develop malnutrition, especially when blood flow is redirected during certain surgeries. It may help explain what contributes to low body weight and muscle so better treatments can be planned in the future.
This study follows people with cirrhosis to see how best to detect liver cancer early. If you qualify, you may receive regular monitoring that could help find liver cancer sooner, when treatment is more likely to work.
This study tests whether offering an ultrasound and a blood test (alpha-fetoprotein) every 6 months can help find liver cancer early in people with cirrhosis (scarred liver) caused by conditions other than hepatitis B or C. The goal is to reduce deaths from liver cancer in this group.
This study looks at how your body uses protein in your muscles when you have cirrhosis (a scarred liver). It uses a special “tracer” method (a substance that can be tracked) and may help researchers better understand muscle loss in people with milder cirrhosis.
This study looks at the nutrition and dietary needs of people with cirrhosis (a type of long-term liver damage). It aims to understand how nutrition affects their health, so doctors can give better advice.
Hear when a new Cirrhosis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.